Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1131 | 2736 | 35.9 | 67% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1704 | 6129 | ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//EMPHYSEMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ALPHA1 ANTITRYPSIN DEFICIENCY | Author keyword | 280 | 66% | 10% | 262 |
2 | ALPHA 1 ANTITRYPSIN | Author keyword | 195 | 42% | 13% | 362 |
3 | ANTITRYPSIN | Author keyword | 32 | 62% | 1% | 33 |
4 | SERPIN | Author keyword | 29 | 19% | 5% | 134 |
5 | AUGMENTATION THERAPY | Author keyword | 22 | 50% | 1% | 32 |
6 | SERPINS | Author keyword | 22 | 29% | 2% | 65 |
7 | PI SUBTYPES | Author keyword | 21 | 85% | 0% | 11 |
8 | LOOP SHEET POLYMERIZATION | Author keyword | 20 | 100% | 0% | 9 |
9 | PI PHENOTYPES | Author keyword | 18 | 89% | 0% | 8 |
10 | SERPINA1 | Author keyword | 14 | 59% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALPHA1 ANTITRYPSIN DEFICIENCY | 280 | 66% | 10% | 262 | Search ALPHA1+ANTITRYPSIN+DEFICIENCY | Search ALPHA1+ANTITRYPSIN+DEFICIENCY |
2 | ALPHA 1 ANTITRYPSIN | 195 | 42% | 13% | 362 | Search ALPHA+1+ANTITRYPSIN | Search ALPHA+1+ANTITRYPSIN |
3 | ANTITRYPSIN | 32 | 62% | 1% | 33 | Search ANTITRYPSIN | Search ANTITRYPSIN |
4 | SERPIN | 29 | 19% | 5% | 134 | Search SERPIN | Search SERPIN |
5 | AUGMENTATION THERAPY | 22 | 50% | 1% | 32 | Search AUGMENTATION+THERAPY | Search AUGMENTATION+THERAPY |
6 | SERPINS | 22 | 29% | 2% | 65 | Search SERPINS | Search SERPINS |
7 | PI SUBTYPES | 21 | 85% | 0% | 11 | Search PI+SUBTYPES | Search PI+SUBTYPES |
8 | LOOP SHEET POLYMERIZATION | 20 | 100% | 0% | 9 | Search LOOP+SHEET+POLYMERIZATION | Search LOOP+SHEET+POLYMERIZATION |
9 | PI PHENOTYPES | 18 | 89% | 0% | 8 | Search PI+PHENOTYPES | Search PI+PHENOTYPES |
10 | SERPINA1 | 14 | 59% | 1% | 16 | Search SERPINA1 | Search SERPINA1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALPHA1 ANTITRYPSIN DEFICIENCY | 550 | 53% | 27% | 731 |
2 | ALPHA 1 ANTITRYPSIN | 163 | 33% | 15% | 411 |
3 | REACTIVE LOOP | 131 | 88% | 2% | 61 |
4 | ANTITRYPSIN DEFICIENCY | 115 | 85% | 2% | 61 |
5 | ALPHA 1 PROTEINASE INHIBITOR | 89 | 28% | 10% | 267 |
6 | AUGMENTATION THERAPY | 84 | 64% | 3% | 82 |
7 | PIZ | 72 | 91% | 1% | 30 |
8 | MUTANT ALPHA1 ANTITRYPSIN Z | 67 | 80% | 1% | 41 |
9 | ALPHA ANTITRYPSIN DEFICIENCY | 65 | 95% | 1% | 21 |
10 | SEVERE ALPHA1 ANTITRYPSIN DEFICIENCY | 64 | 79% | 1% | 41 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Current status of gene therapy for alpha-1 antitrypsin deficiency | 2015 | 2 | 57 | 54% |
Suspecting and Testing for Alpha-1 Antitrypsin Deficiency-An Allergist's and/or Immunologist's Perspective | 2015 | 1 | 26 | 96% |
A Review of alpha(1)-Antitrypsin Deficiency | 2012 | 61 | 143 | 81% |
Acute-phase protein alpha 1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats | 2015 | 1 | 119 | 64% |
alpha 1-antitrypsin deficiency | 2005 | 223 | 91 | 82% |
The molecular and cellular pathology of alpha(1)-antitrypsin deficiency | 2014 | 8 | 110 | 86% |
THE SERPIN SUPERFAMILY OF PROTEINASE-INHIBITORS - STRUCTURE, FUNCTION, AND REGULATION | 1994 | 692 | 68 | 51% |
Conformational Pathology of the Serpins: Themes, Variations, and Therapeutic Strategies | 2009 | 83 | 142 | 78% |
Hereditary alpha-I-antitrypsin deficiency and its clinical consequences | 2008 | 53 | 28 | 89% |
alpha(1)-Antitrypsin deficiency center dot 1: Epidemiology of alpha(1)-antitrypsin deficiency | 2004 | 123 | 26 | 85% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EVALUAT RISKS HUMAN REPROD | 9 | 83% | 0.2% | 5 |
2 | LUNG INVEST UNIT | 9 | 37% | 0.7% | 19 |
3 | AD T PROJECT | 8 | 75% | 0.2% | 6 |
4 | PROT STRAIN | 8 | 100% | 0.2% | 5 |
5 | LUNG FUNCT SLEEP | 6 | 50% | 0.3% | 9 |
6 | DIAG INHERITED ANTITRYPSIN DEFICIENCY ALPHA1 | 3 | 100% | 0.1% | 3 |
7 | PEDIATUPMC NEWBORN MED PROGRAM | 3 | 100% | 0.1% | 3 |
8 | SPANISH SOC PNEUMOL SEPAR | 3 | 100% | 0.1% | 3 |
9 | U392 ENZYMOL | 3 | 100% | 0.1% | 3 |
10 | CLIN MALATTIE PARATO P BIOCHIM GENET | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000108125 | ANIMAL BLOOD GROUPS AND BIOCHEMICAL GENETICS//ALPHA PROTEASE INHIBITORS//ALPHA 1 BETA GLYCOPROTEIN |
2 | 0.0000107262 | HEPARIN COFACTOR II//ANTITHROMBIN//ANTITHROMBIN DEFICIENCY |
3 | 0.0000105759 | COPD RELATED PHENOTYPES//IREB2//FAM13A |
4 | 0.0000105310 | ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR |
5 | 0.0000095793 | MEGSIN//SERPINB2//PAI 2 |
6 | 0.0000059537 | ALPHA 1 ANTICHYMOTRYPSIN DEFICIENCY//PULMONARY ADENOCARCINOMA CELL LINE//SERPINE |
7 | 0.0000056675 | PROTEIN C INHIBITOR//MCFD2//F5F8D |
8 | 0.0000055347 | CLIN PATHOL BIOCHEM//ALPHA2 ANTIPLASMIN//TC 99M NC100668 |
9 | 0.0000054082 | OVOMUCIN//S OVALBUMIN//OVOTRANSFERRIN |
10 | 0.0000042891 | SQUAMOUS CELL CARCINOMA ANTIGEN//SCC ANTIGEN//SERPINB3 |